Literature DB >> 21430138

Anatomically defined neuron-based rescue of neurodegenerative Niemann-Pick type C disorder.

Manuel E Lopez1, Andres D Klein, Ubah J Dimbil, Matthew P Scott.   

Abstract

Niemann-Pick type C disease is a fatal lysosomal storage disorder caused by loss of NPC1 function. The disorder severely affects multiple body systems, particularly the nervous system. To test whether rescue of NPC1 activity in neurons, astrocytes, or other cell types can correct the neurological defects, a Tet-inducible Npc1-YFP transgene was introduced into Npc1(-/-) mice for the cell type-specific rescue of NPC1 loss. NPC1-YFP produced in neurons prevented neuron degeneration, slowed reactive glial activity, and ameliorated the disease. NPC1-YFP produced in astrocytes or in cells of visceral tissue did not. These results suggest that loss of NPC1 activity from neurons is the primary cause of the neuropathology and that rescue of NPC1 function in neurons is sufficient to mitigate the disease. The ability of neurons to survive and function in a cell-autonomous fashion allowed the use of this newly engineered rescue system to further define the brain regions or neuron populations required to ameliorate a neurological symptom. NPC1-YFP produced specifically in cerebellar Purkinje neurons reduced ataxia, increased weight, and prolonged life, but it did not prevent the eventual decline and premature death of Npc1(-/-) mice. Significant increase in lifespan correlated with sustained reduction of inflammation in the thalamus. Neuron rescue of other forebrain areas provided little benefit. Future work targeting increasingly discrete neuronal networks should reveal which CNS areas are critical for survival. This work may have broad implications for understanding the anatomical and cellular basis of neurological signs and symptoms of other neurodegenerative and lysosomal disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21430138      PMCID: PMC3071647          DOI: 10.1523/JNEUROSCI.5981-10.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

Review 1.  Patterned Purkinje cell death in the cerebellum.

Authors:  Justyna R Sarna; Richard Hawkes
Journal:  Prog Neurobiol       Date:  2003-08       Impact factor: 11.685

Review 2.  Type C Niemann-Pick disease: biochemical aspects and phenotypic heterogeneity.

Authors:  M T Vanier; C Rodriguez-Lafrasse; R Rousson; S Duthel; K Harzer; P G Pentchev; A Revol; P Louisot
Journal:  Dev Neurosci       Date:  1991       Impact factor: 2.984

Review 3.  Astrocytic dysfunction: insights on the role in neurodegeneration.

Authors:  Daniela Rossi; Andrea Volterra
Journal:  Brain Res Bull       Date:  2009-07-22       Impact factor: 4.077

4.  Characterization of liver disease and lipid metabolism in the Niemann-Pick C1 mouse.

Authors:  William S Garver; David Jelinek; Janice N Oyarzo; James Flynn; Matthew Zuckerman; Kumar Krishnan; Byung H Chung; Randall A Heidenreich
Journal:  J Cell Biochem       Date:  2007-05-15       Impact factor: 4.429

5.  Transgenic animals with inducible, targeted gene expression in brain.

Authors:  J Chen; M B Kelz; G Zeng; N Sakai; C Steffen; P E Shockett; M R Picciotto; R S Duman; E J Nestler
Journal:  Mol Pharmacol       Date:  1998-09       Impact factor: 4.436

6.  Improvement in lipid and protein trafficking in Niemann-Pick C1 cells by correction of a secondary enzyme defect.

Authors:  Cecilia Devlin; Nina H Pipalia; Xianghai Liao; Edward H Schuchman; Frederick R Maxfield; Ira Tabas
Journal:  Traffic       Date:  2010-02-22       Impact factor: 6.215

7.  Murine models of acute neuronopathic Gaucher disease.

Authors:  Ida Berglin Enquist; Christophe Lo Bianco; Andreas Ooka; Eva Nilsson; Jan-Eric Månsson; Mats Ehinger; Johan Richter; Roscoe O Brady; Deniz Kirik; Stefan Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-22       Impact factor: 11.205

8.  Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia.

Authors:  Michel Baudry; Yuequin Yao; Danielle Simmons; Jihua Liu; Xiaoning Bi
Journal:  Exp Neurol       Date:  2003-12       Impact factor: 5.330

9.  Brainstem neuropathology in a mouse model of Niemann-Pick disease type C.

Authors:  Zhuo Luan; Yoshiaki Saito; Hajime Miyata; Eisaku Ohama; Haruaki Ninomiya; Kousaku Ohno
Journal:  J Neurol Sci       Date:  2008-01-10       Impact factor: 3.181

10.  GFAP promoter elements required for region-specific and astrocyte-specific expression.

Authors:  Youngjin Lee; Albee Messing; Mu Su; Michael Brenner
Journal:  Glia       Date:  2008-04       Impact factor: 7.452

View more
  53 in total

1.  Normalization of cholesterol homeostasis by 2-hydroxypropyl-β-cyclodextrin in neurons and glia from Niemann-Pick C1 (NPC1)-deficient mice.

Authors:  Kyle B Peake; Jean E Vance
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

2.  Rescue of an in vitro neuron phenotype identified in Niemann-Pick disease, type C1 induced pluripotent stem cell-derived neurons by modulating the WNT pathway and calcium signaling.

Authors:  Anastasia G Efthymiou; Joe Steiner; William J Pavan; Stephen Wincovitch; Denise M Larson; Forbes D Porter; Mahendra S Rao; Nasir Malik
Journal:  Stem Cells Transl Med       Date:  2015-01-30       Impact factor: 6.940

Review 3.  Current controversies in Niemann-Pick C1 disease: steroids or gangliosides; neurons or neurons and glia.

Authors:  Robert P Erickson
Journal:  J Appl Genet       Date:  2013-01-05       Impact factor: 3.240

Review 4.  Finding degrees of separation: experimental approaches for astroglial and oligodendroglial cell isolation and genetic targeting.

Authors:  Li-Jin Chew; Cynthia A DeBoy; Vladimir V Senatorov
Journal:  J Neurosci Methods       Date:  2014-08-26       Impact factor: 2.390

5.  Astrocytic TGF-β signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection.

Authors:  Egle Cekanaviciute; Hans K Dietrich; Robert C Axtell; Aaron M Williams; Riann Egusquiza; Karen M Wai; Anita A Koshy; Marion S Buckwalter
Journal:  J Immunol       Date:  2014-05-23       Impact factor: 5.422

6.  Subcortical volumetric reductions in adult Niemann-Pick disease type C: a cross-sectional study.

Authors:  M Walterfang; B Patenaude; L A Abel; H Kluenemann; E A Bowman; M C Fahey; P Desmond; W Kelso; D Velakoulis
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-13       Impact factor: 3.825

7.  Ryanodine receptor antagonists adapt NPC1 proteostasis to ameliorate lipid storage in Niemann-Pick type C disease fibroblasts.

Authors:  Ting Yu; Chan Chung; Dongbiao Shen; Haoxing Xu; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2012-04-14       Impact factor: 6.150

Review 8.  The Extending Spectrum of NPC1-Related Human Disorders: From Niemann-Pick C1 Disease to Obesity.

Authors:  Amel Lamri; Marie Pigeyre; William S Garver; David Meyre
Journal:  Endocr Rev       Date:  2018-04-01       Impact factor: 19.871

9.  Proteomic analysis of mouse models of Niemann-Pick C disease reveals alterations in the steady-state levels of lysosomal proteins within the brain.

Authors:  David E Sleat; Jennifer A Wiseman; Istvan Sohar; Mukarram El-Banna; Haiyan Zheng; Dirk F Moore; Peter Lobel
Journal:  Proteomics       Date:  2012-11-22       Impact factor: 3.984

Review 10.  Modeling Niemann Pick type C1 using human embryonic and induced pluripotent stem cells.

Authors:  M Paulina Ordoñez; John W Steele
Journal:  Brain Res       Date:  2016-03-10       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.